HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No 12, December 2019 – Precision Medicine for Brain Tumours       » First Alzheimer's drug to be approved in 17 years holds promise for treatment       » Tencent make medical information readily available to the public       » United States FDA approves first China-made cancer drug       » Value-Based Healthcare: A Paradigm Shift for Better Patient Outcomes       » Precision Agriculture for Future Nutritional Needs      
EYE ON CHINA
Vaccine shortage hits many parts of China
Shortages of some category 1 vaccines, which are provided free of charge by the government, have become more frequent in China recently, CCTV reported.

Shenzhen's Center for Disease Control and Prevention announced in early July that the city was experiencing a serious shortage of DPT (diphtheria-pertussis-tetanus) vaccines, which fell 175,000 doses short of demand. Supplies also couldn't meet the demand for other category 1 vaccines, including those for leprosy, Japanese encephalitis (JE) and epidemic cerebrospinal meningitis group A and C.

A similar situation has troubled South China's Guangxi Zhuang autonomous region.

According to Guangxi's Center for Disease Control and Prevention, the area was in short supply of five category 1 vaccines: leprosy, MMR (measles-mumps-rubella), DTP, hepatitis A and JE. The leprosy vaccine supply faced the largest gap with its demand, with a supply rate of less than 20 percent.

Since Jan 1, statistics on supply rates have recorded the DTP vaccine at 32 percent, MMR vaccine at 59 percent, hepatitis A vaccine at 72 percent and JE vaccine at 60 percent.

A woman surnamed Long from Nanning, Guangxi, said the DTP vaccine had been out of supply since May 8. Her 8-month-old child should have completed vaccinations for another two injections by now, but the process was suspended for over two months, making her a bit worried.

Many parents in Guangxi have had the same worry as Ms. Long. Another Nanning resident said he had chosen to pay for the vaccine rather than keep waiting until free vaccines became more available.

Running out of vaccine stock has been a nationwide phenomenon, mainly caused by the insufficient production capability of manufacturers, said an official from the Disease Control and Prevention Center in Guangxi.

Currently there is no sign that the supply and demand gap can be filled in the short term, the official added.

According to a report from Beijing News, regions including Sichuan, Gansu, Guizhou, Anhui, Shaanxi and Hainan also have reported shortages in supplies of certain category 1 vaccines.

The official suggested parents can choose to pay on their own to have children receive category 2 vaccines, which, like category 1 options, can also provide immunity against diseases.

Source: China Daily

Click here for the complete issue.

NEWS CRUNCH  
news Proteona awards grant to clinician-scientist for research in treatment selection of multiple myeloma
news Technology giant, Tencent Holdings Limited, promotes medical science and healthcare
news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
December:
Precision Medicine for Brain Tumours
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy